Neonatal Jaundice. Neonatal jaundice from other and unspecified causes
Conditions
Interventions
Intervention 1: Intervention group No.1: Synbiotic Group (Pedilact) ecipient of 5 drops every twelve hours of Pedilact product produced by Iran Bio Fermentation Company, in addition to receiving daily
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 28 Days
Inclusion criteria
Inclusion criteria: Term neonate (GA>35w) Birth weight > 2500g Breast milk feeding Indication for phototherapy and hospitalization by Bhutani chart
Exclusion criteria
Exclusion criteria: Less than 2 days old With a pathological background such as sepsis, favism, congenital anomalies, asphyxia, congenital heart disease and intrauterine growth restriction With a positive Coombs test Undergoing blood transfusion or receiving IVIG Treated with phenobarbital In need of serum therapy Consumption of Formula
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin level (mg/dl). Timepoint: Daily up to 5 days. Method of measurement: Serum Bilirubin Level. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fecal count. Timepoint: Daily. Method of measurement: Enumeration.;Urination. Timepoint: Daily. Method of measurement: Enumeration.;Hospitalization time. Timepoint: Daily. Method of measurement: Enumeration. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhossein Khosravinejad
Yazd University of Medical Sciences
Outcome results
None listed